1 recruiting, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
Follow Pulmonary Artery Hypertension: new trials by email Literature Review of Pulmonary Artery Hypertension trials Research Report on Pulmonary Artery Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension reserpine, stellate ganglion block, lidocaine - Pulmonary Artery Hypertension | Phase 1 | Withdrawn | Mayo Clinic | 2016-07-01 | 2019-05-22 | |
| : Vascular Function in Health and Disease Maximum Exercise Tests, BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-Ascorbate, BQ-123 - Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension | Phase 1 | Recruiting | D. Walter Wray | 420 | 2008-09-01 | 2026-09-25 |
Familial Primary Pulmonary Hypertension (2) · Heart Failure (1) · Hypertension (1) · Pulmonary Disease, Chronic Obstructive (1)
Hypertension, Pulmonary (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Heart Diseases (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
Acetylcholine (1) · Angiotensin I (1) · Ascorbic Acid (1) · Lidocaine (1) · Nitroprusside (1) · Norepinephrine (1) · Phentolamine (1) · Ranitidine (1) · Reserpine (1) · Thioctic Acid (1) · Valsartan (1) · Vitamin E (1) · cyclo(Trp-Asp-Pro-Val-Leu) (1) · fexofenadine (1) · mitoquinone (1)
D. Walter Wray (1) · Mayo Clinic (1)
United States (2)
David W Wray, Ph.D. (1) · Joseph Blackshear, MD (1)